STOCK TITAN

Director of CAMTEK (NASDAQ: CAMT) discloses options and share stake in Form 3

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

CAMTEK LTD director Yosef Shacham filed an initial Form 3 detailing his existing equity stake in the company. The filing lists several stock options to buy ordinary shares, including 1,426 shares at an exercise price of $36.45 expiring on 2028-08-18 and 3,176 shares at $22.63 expiring on 2029-11-10. It also shows options for 880 shares at $63.51, 1,132 shares at $81.28 and 1,095 shares at $59.76 with expirations from 2030 to 2032. In addition, he holds 5,852 and 628 ordinary shares, some issued upon vesting of restricted stock units, with certain RSUs and options vesting at the company’s 2026 annual meeting of shareholders subject to continued service.

Positive

  • None.

Negative

  • None.
Insider Shacham Yosef
Role Director
Type Security Shares Price Value
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Ordinary Shares -- -- --
holding Ordinary Shares -- -- --
Holdings After Transaction: Stock Option (Right to Buy) — 1,426 shares (Direct); Ordinary Shares — 5,852 shares (Direct)
Footnotes (1)
  1. These shares were issued upon vesting of previously granted restricted stock units ("RSUs"), which each represent a contingent right to receive one ordinary share of Camtek Ltd. (the "Company"). The Reporting Person was granted RSUs, which each represent a contingent right to receive one ordinary share of the Company. The RSUs will vest on the date of the Companys 2026 annual meeting of shareholders, subject to continued service through the vesting date. The Stock Options are Fully vested and immediately exercisable The options will vest on the date of the Companys 2026 annual meeting of shareholders, subject to continued service through the vesting date.
Option grant 1 1,426 shares at $36.45 Stock option; exercise price; expiration 2028-08-18
Option grant 2 3,176 shares at $22.63 Stock option; exercise price; expiration 2029-11-10
Option grant 3 880 shares at $63.51 Stock option; exercise price; expiration 2030-12-21
Option grant 4 1,132 shares at $81.28 Stock option; exercise price; expiration 2031-09-25
Option grant 5 1,095 shares at $59.76 Stock option; exercise price; expiration 2032-04-29
Ordinary shares holding 1 5,852 shares Directly held CAMTEK ordinary shares
Ordinary shares holding 2 628 shares Additional directly held CAMTEK ordinary shares
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
Ordinary Shares financial
"underlying_security_title": "Ordinary Shares""
Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.
restricted stock units ("RSUs") financial
"These shares were issued upon vesting of previously granted restricted stock units ("RSUs")"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
exercise price financial
""conversion_or_exercise_price": "36.4500""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
""expiration_date": "2032-04-29T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
annual meeting of shareholders financial
"will vest on the date of the Companys 2026 annual meeting of shareholders"
A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Shacham Yosef

(Last)(First)(Middle)
13 HANOTRIM ST.

(Street)
ZICHRON YAAKOV

(City)(State)(Zip)

ISRAEL

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
04/13/2026
3. Issuer Name and Ticker or Trading Symbol
CAMTEK LTD [ CAMT ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares5,852(1)D
Ordinary Shares628(2)D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)11/10/2022(3)08/18/2028Ordinary Shares1,426$36.45D
Stock Option (Right to Buy)12/21/2023(3)11/10/2029Ordinary Shares3,176$22.63D
Stock Option (Right to Buy)09/25/2024(3)12/21/2030Ordinary Shares880$63.51D
Stock Option (Right to Buy)04/29/2025(3)09/25/2031Ordinary Shares1,132$81.28D
Stock Option (Right to Buy) (4)04/29/2032Ordinary Shares1,095$59.76D
Explanation of Responses:
1. These shares were issued upon vesting of previously granted restricted stock units ("RSUs"), which each represent a contingent right to receive one ordinary share of Camtek Ltd. (the "Company").
2. The Reporting Person was granted RSUs, which each represent a contingent right to receive one ordinary share of the Company. The RSUs will vest on the date of the Companys 2026 annual meeting of shareholders, subject to continued service through the vesting date.
3. The Stock Options are Fully vested and immediately exercisable
4. The options will vest on the date of the Companys 2026 annual meeting of shareholders, subject to continued service through the vesting date.
Remarks:
This Form 3 has been filed after March 18, 2026 but prior to April 20, 2026 in reliance on the temporary relief made available to the directors and officers of certain foreign private issuers by the Staff of the Securities and Exchange Commission in its no-action letter dated March 13, 2026.
Yossi Shacham by: Oppenheimer Israel, as Attorney-in-fact04/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the CAMT Form 3 filing by Yosef Shacham report?

The Form 3 for CAMTEK LTD (CAMT) reports director Yosef Shacham’s existing holdings. It lists multiple stock option grants and ordinary shares he already owns, establishing his baseline ownership when he became a reporting insider.

How many CAMTEK (CAMT) options does Yosef Shacham hold according to the Form 3?

The filing shows several option grants, including 1,426 shares at $36.45, 3,176 shares at $22.63, 880 shares at $63.51, 1,132 shares at $81.28, and 1,095 shares at $59.76, each representing rights to acquire CAMTEK ordinary shares.

What ordinary share holdings for CAMT are disclosed for Yosef Shacham?

The Form 3 discloses that Yosef Shacham holds 5,852 ordinary shares and an additional 628 ordinary shares of CAMTEK LTD. Some of these shares were issued upon vesting of previously granted restricted stock units, according to the footnotes.

Are Yosef Shacham’s CAMT stock options already vested or still vesting?

Footnotes state some stock options are fully vested and immediately exercisable, while other options and RSUs will vest on the date of CAMTEK’s 2026 annual meeting of shareholders, subject to his continued service through that vesting date.

Does the CAMT Form 3 show any recent buying or selling by Yosef Shacham?

The Form 3 primarily lists holdings rather than transactions. The structured data show no buy or sell codes, indicating this filing establishes Shacham’s existing position instead of reporting new open-market purchases or sales.